ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 196 filers reported holding ARRAY BIOPHARMA INC in Q1 2017. The put-call ratio across all filers is 0.57 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $2,298,000 | -20.8% | 94,275 | -47.0% | 0.56% | +16.8% |
| Q1 2018 | $2,901,000 | +38.3% | 177,747 | +8.5% | 0.48% | +28.5% |
| Q4 2017 | $2,097,000 | -15.7% | 163,818 | -19.0% | 0.38% | +13.6% |
| Q3 2017 | $2,488,000 | +321.7% | 202,309 | +201.2% | 0.33% | +324.4% |
| Q4 2016 | $590,000 | -40.0% | 67,178 | -53.9% | 0.08% | -40.9% |
| Q3 2016 | $983,000 | -10.6% | 145,682 | -2.3% | 0.13% | +3.9% |
| Q1 2015 | $1,099,000 | – | 149,121 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Advisory Services Network, LLC | 3,442 | $159,000 | 0.01% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |